Catalyst Wire Dossier Catalyst Wire Dossier

RITALIN LA

methylphenidate hydrochloride
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RITALIN LA, covering 2011-07-12 to 2011-07-12. Get the full timeline:

Most recent: Clinical Trial Update: A Double-blind Randomized, Placebo-controlled, Crossover Study of Single Doses of OROS Methylphenidate Hydrochloride (CONCERTA) and Long-acting Methylphenidate Hydrochloride (RITALIN LA) in Healthy Adults [Phase 4]

See pricing